Combining immunotherapies: inhibiting the CTLA-4 and PD-1 pathways

Share :
Published: 10 Mar 2015
Views: 4612
Rating:
Save
Prof Mario Sznol - Yale Cancer Center, New Haven, USA

Professor Sznol talks to ecancertv at TAT 2015 about his work on anti-CTLA-4 and anti-PD-1 inhibitors, which he is combining to activate the immune response against cancer.